DE69132575D1 - Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe - Google Patents

Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe

Info

Publication number
DE69132575D1
DE69132575D1 DE69132575T DE69132575T DE69132575D1 DE 69132575 D1 DE69132575 D1 DE 69132575D1 DE 69132575 T DE69132575 T DE 69132575T DE 69132575 T DE69132575 T DE 69132575T DE 69132575 D1 DE69132575 D1 DE 69132575D1
Authority
DE
Germany
Prior art keywords
sampangine
antimycobacterial
antimycotic
derivatives
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132575T
Other languages
English (en)
Other versions
DE69132575T2 (de
Inventor
Alice M Clark
Charles D Hufford
Shihchih Liu
Babajide O Oguntimein
John R Peterson
Jordan K Zjawiony
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MISSISSIPPI RES INST OF P, University of
Original Assignee
MISSISSIPPI RES INST OF P, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MISSISSIPPI RES INST OF P, University of filed Critical MISSISSIPPI RES INST OF P, University of
Application granted granted Critical
Publication of DE69132575D1 publication Critical patent/DE69132575D1/de
Publication of DE69132575T2 publication Critical patent/DE69132575T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69132575T 1991-06-14 1991-11-06 Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe Expired - Fee Related DE69132575T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/715,776 US5227383A (en) 1991-06-14 1991-06-14 Compounds and compositions useful as antifungal and antimycobacterial agents
PCT/US1991/008319 WO1992022297A1 (en) 1991-06-14 1991-11-06 New compounds and compositions useful as antifungal and antimycobacterial agents

Publications (2)

Publication Number Publication Date
DE69132575D1 true DE69132575D1 (de) 2001-05-10
DE69132575T2 DE69132575T2 (de) 2001-10-18

Family

ID=24875436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132575T Expired - Fee Related DE69132575T2 (de) 1991-06-14 1991-11-06 Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe

Country Status (10)

Country Link
US (2) US5227383A (de)
EP (1) EP0588796B1 (de)
JP (1) JP3405540B2 (de)
AT (1) ATE200223T1 (de)
CA (1) CA2111338A1 (de)
DE (1) DE69132575T2 (de)
DK (1) DK0588796T3 (de)
ES (1) ES2157899T3 (de)
GR (1) GR3036159T3 (de)
WO (1) WO1992022297A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4301424A1 (de) * 1993-01-20 1994-07-21 Basf Ag Derivate des Azaanthrachinons und des Azaxanthons und diese enthaltende Herbizide und Pflanzenwachstumsregulatoren
US5476933A (en) * 1994-11-16 1995-12-19 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Azepine synthesis via a diels-alder reaction
US20040052868A1 (en) 2002-09-12 2004-03-18 William Asiedu Composition treating for AIDS and associated conditions
AU2011219481B2 (en) * 2002-09-12 2012-09-20 Willfred-Ramix, Inc. A composition for treating AIDS and associated conditions
JP4794136B2 (ja) * 2004-04-21 2011-10-19 阿蘇製薬株式会社 アクリジン誘導体
US7491721B2 (en) * 2004-05-12 2009-02-17 Lupin Limited Antimycobacterial pharmaceutical composition
US20170112824A1 (en) * 2015-10-23 2017-04-27 Wright State University Combination therapies for the treatment of fungal infections
CN106905317B (zh) * 2017-01-24 2019-03-22 广西师范大学 4-取代Sampangine生物碱衍生物及其合成方法和应用
BR112020025923A2 (pt) 2018-06-18 2021-04-06 Elc Management Llc Compostos fotoestabilizantes, composições e métodos
KR102531948B1 (ko) * 2018-06-18 2023-05-12 이엘씨 매니지먼트 엘엘씨 광안정화 화합물, 조성물, 및 방법
ES2924855T3 (es) 2018-06-18 2022-10-11 Elc Man Llc Compuestos, composiciones y métodos fotoestabilizadores
CN113461506A (zh) * 2021-06-23 2021-10-01 苏州求索生物科技有限公司 一种2-溴-1,4-萘并醌的制备工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080456A (en) * 1971-10-26 1978-03-21 Schering Aktiengesellschaft Diacylapomorphines
AR204011A1 (es) * 1973-07-27 1975-11-12 Rhone Poulenc Sa Procedimiento de preparacion de nuevos derivados de 7-h-indolizino(5,6,7-ij)isoquinoleina
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
US4965272A (en) * 1988-07-14 1990-10-23 Hufford Charles D Antimicrobial compound and compositions particularly effective against candida albicans
US5128344A (en) * 1990-11-06 1992-07-07 University Of Mississippi Sampangine and derivatives useful as an antifungal agent

Also Published As

Publication number Publication date
JPH06508104A (ja) 1994-09-14
US5530004A (en) 1996-06-25
EP0588796B1 (de) 2001-04-04
JP3405540B2 (ja) 2003-05-12
DK0588796T3 (da) 2001-05-07
EP0588796A4 (en) 1994-09-14
GR3036159T3 (en) 2001-09-28
DE69132575T2 (de) 2001-10-18
WO1992022297A1 (en) 1992-12-23
EP0588796A1 (de) 1994-03-30
ATE200223T1 (de) 2001-04-15
CA2111338A1 (en) 1992-12-23
ES2157899T3 (es) 2001-09-01
US5227383A (en) 1993-07-13

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
ES2040208T3 (es) Pirazolinas insecticidas.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
NO971568L (no) Analoger av keratinocyttvekstfaktor
ATE212351T1 (de) Androsten-derivate
ATE121287T1 (de) Verfahren zur behandlung der alopezie.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
DE69132575D1 (de) Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
NO890046D0 (no) Disubstituerte pyridiner.
DE69232417T2 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69728536D1 (de) Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
SE9504662D0 (sv) New compounds
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
DE69230644T2 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
IT1255728B (it) Derivati di s-triazina ad azione fotoprotettiva
ATE44149T1 (de) N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide.
ECSP961762A (es) Compuestos antibacterianos
RU94035756A (ru) Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee